Notice of Approval of Supplemental New Animal Drug Application; Ivermectin and Praziquantel Paste

Короткий зміст

The Food and Drug Administration (FDA) is providing notice that it has approved a supplemental new animal drug application (NADA) filed by Virbac AH, Inc. The supplemental NADA provides for use of an ivermectin and praziquantel oral paste for the treatment and control of various species of internal parasites in mares intended for breeding purposes.